Boron Bone Turnover Randomized Trial Evidence Table

Structured evidence table for Boron Bone Turnover Randomized Trial, generated from 1 reusable source document in the Migaku knowledge base.

topicclaimevidence levelcitationsource
Boron Bone Turnover Randomized TrialResults The results showed that MMF exposure significantly improved BMD, bone mineral content (BMC), bone microarchitecture and bone strength in OVX mice.2Wang S (2025)Moderate static magnetic fields prevent estrogen deficiency-induced bone loss: Evidence from ovariectomized mouse model and small sample size randomized controlled clinical trial.
Boron Bone Turnover Randomized TrialFor bone turnover, MMF increased the number of osteoblasts on the bone surface of OVX mice as well as the level of serum bone formation marker P1NP, while decreasing the number of osteoclasts and the level of serum bone resorption marker β-CTX.2Wang S (2025)Moderate static magnetic fields prevent estrogen deficiency-induced bone loss: Evidence from ovariectomized mouse model and small sample size randomized controlled clinical trial.
Boron Bone Turnover Randomized TrialThe clinical trial's results showed that MMF treatment had a positive effect on the improvement of BMD in the lumbar spine and increased serum P1NP levels while decreased β-CTX levels.2Wang S (2025)Moderate static magnetic fields prevent estrogen deficiency-induced bone loss: Evidence from ovariectomized mouse model and small sample size randomized controlled clinical trial.
Boron Bone Turnover Randomized TrialBackground Postmenopausal osteoporosis (PMOP) is the most common type of osteoporosis.2Wang S (2025)Moderate static magnetic fields prevent estrogen deficiency-induced bone loss: Evidence from ovariectomized mouse model and small sample size randomized controlled clinical trial.
topicBoron Bone Turnover Randomized Trial
claimResults The results showed that MMF exposure significantly improved BMD, bone mineral content (BMC), bone microarchitecture and bone strength in OVX mice.
evidence level2
citationWang S (2025)
sourceModerate static magnetic fields prevent estrogen deficiency-induced bone loss: Evidence from ovariectomized mouse model and small sample size randomized controlled clinical trial.
topicBoron Bone Turnover Randomized Trial
claimFor bone turnover, MMF increased the number of osteoblasts on the bone surface of OVX mice as well as the level of serum bone formation marker P1NP, while decreasing the number of osteoclasts and the level of serum bone resorption marker β-CTX.
evidence level2
citationWang S (2025)
sourceModerate static magnetic fields prevent estrogen deficiency-induced bone loss: Evidence from ovariectomized mouse model and small sample size randomized controlled clinical trial.
topicBoron Bone Turnover Randomized Trial
claimThe clinical trial's results showed that MMF treatment had a positive effect on the improvement of BMD in the lumbar spine and increased serum P1NP levels while decreased β-CTX levels.
evidence level2
citationWang S (2025)
sourceModerate static magnetic fields prevent estrogen deficiency-induced bone loss: Evidence from ovariectomized mouse model and small sample size randomized controlled clinical trial.
topicBoron Bone Turnover Randomized Trial
claimBackground Postmenopausal osteoporosis (PMOP) is the most common type of osteoporosis.
evidence level2
citationWang S (2025)
sourceModerate static magnetic fields prevent estrogen deficiency-induced bone loss: Evidence from ovariectomized mouse model and small sample size randomized controlled clinical trial.

Source documents

  1. Moderate static magnetic fields prevent estrogen deficiency-induced bone loss: Evidence from ovariectomized mouse model and small sample size randomized controlled clinical trial.